Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBI 226 in Acne Vulgaris
NCT00211523Phase 2Completed
- Sponsor
- BioWest Therapeutics
- Start
- Oct 2000
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 2 trial of omiganan in acne vulgaris, sponsored by BioWest Therapeutics. Started Oct 2000; status: completed.
02
Drugs
omiganan
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00211523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00211523.